Genoks, a leading Turkish genomics healthcare company, and Velsera, a global healthcare technology company, have partnered to advance cancer diagnostics and treatment in Turkey and nearby regions. This collaboration leverages Genoks' expertise in genomics and Velsera's Clinical Genomics Workspace (CGW), a platform designed for comprehensive analysis of solid tissue, liquid tumor, and hematological cancer samples. Integrating CGW into Genoks' services will enhance its ability to detect and characterize various cancers accurately, providing precise insights for treatment decisions.
The partnership aims to elevate oncology diagnostics in Turkey, offering state-of-the-art testing solutions for personalized cancer care. Velsera's advanced algorithms will empower Genoks to deliver actionable insights tailored to each patient's genetic profile. This collaboration highlights the importance of strategic partnerships in accelerating cancer research and improving patient outcomes, with Genoks and Velsera dedicated to making a significant impact on the fight against cancer in Turkey and beyond.
No comments yet